Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
serious bruise; This serious case was reported by a consumer via interactive digital media and described the occurrence of contusion in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced contusion (Verbatim: serious bruise) (serious criteria other: Serious as per reporter). The outcome of the contusion was not resolved. It was unknown if the reporter considered the contusion to be related to Shingrix. The company considered the contusion to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 12-MAY-2025 This case was reported by the reporter via (Pharmacy Shingrix Program) interactive digital media. The reporter stated patient still have a serious bruise on his/her arm from the 1st Shingrix shot he/she received from. The patient would be going elsewhere for his/her 2nd shot.; Sender's Comments: Contusion is an unlisted event which is considered unrelated to GSK vaccine Shingrix.